Before joining Codiak, Konstantin Konstantinov was responsible for the late-stage bioprocess and technology development at Sanofi’s Boston Hub, including all functions, from cell banking to fill/finish/lyophilization.
Prior to Sanofi, Dr. Konstantinov worked for Bayer in Berkeley, Calif. for 14 years, advancing to the position of Head of Process Sciences. He has published 60 peer reviewed papers and has more than 15 patents and patent applications.
During the last 23 years, Dr. Konstantinov has worked on the development and commercialization of various products, including monoclonal antibodies, blood factors and enzymes expressed in mammalian cells. Most recently, he has pioneered the development of an end-to-end integrated continuous biomanufacturing platform, which is becoming a strategic technological trend for the biomanufacturing industry worldwide.
Dr. Konstantinov received his Ph.D. in Biochemical Engineering from Osaka University, Japan, which was followed by a post-doctoral assignment at DuPont and the University of Delaware.
What is Konstantin Konstantinov's net worth?
The estimated net worth of Konstantin Konstantinov is at least $2.77 as of January 20th, 2023. Dr. Konstantinov owns 1,731 shares of Codiak BioSciences stock worth more than $3 as of April 19th. This net worth estimate does not reflect any other assets that Dr. Konstantinov may own. Learn More about Konstantin Konstantinov's net worth.
How old is Konstantin Konstantinov?
How do I contact Konstantin Konstantinov?
Has Konstantin Konstantinov been buying or selling shares of Codiak BioSciences?
Konstantin Konstantinov has not been actively trading shares of Codiak BioSciences during the past quarter. Most recently, Konstantin Konstantinov sold 1,069 shares of the business's stock in a transaction on Friday, January 20th. The shares were sold at an average price of $0.58, for a transaction totalling $620.02. Following the completion of the sale, the chief technology officer now directly owns 1,731 shares of the company's stock, valued at $1,003.98. Learn More on Konstantin Konstantinov's trading history.
Who are Codiak BioSciences' active insiders?
